DexCom’s “Dexcom State of Type 2 Report: Unveiling Insights into European and Middle Eastern Access and Attitudes
Edinburgh, Scotland and San Diego, CA – In an exciting development for the diabetes community, DexCom, Inc., a pioneering company in glucose biosensing, recently unveiled the findings of its first multi-region report, the “Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East.” This comprehensive study surveyed an impressive cohort of over 2,500 individuals, comprised of individuals living with Type 2 diabetes and healthcare professionals, from Germany, Italy, the Netherlands, Saudi Arabia, Spain, and the United Kingdom.
Key Findings
The report sheds light on various aspects of Type 2 diabetes management in these six countries, including access to continuous glucose monitoring (CGM) systems, attitudes towards diabetes self-management, and healthcare professional recommendations. Some notable findings include:
- CGM usage: The study revealed that CGM usage varies significantly across the six countries, with the highest usage observed in the Netherlands (28%) and the lowest in Germany (12%).
- Attitudes towards self-management: The majority of participants expressed a positive attitude towards self-management, with 70% agreeing that they feel in control of their diabetes. However, 30% reported feeling overwhelmed by the demands of managing their condition.
- Healthcare professional recommendations: The report highlighted that healthcare professionals in Europe and the Middle East generally recommend CGM use to their patients with Type 2 diabetes, with 77% of healthcare professionals surveyed in the Netherlands recommending CGM compared to 43% in Saudi Arabia.
What Does This Mean for Me?
If you are living with Type 2 diabetes, these findings can provide valuable insights into the experiences of others in similar situations. For those in countries where CGM usage is lower, such as Germany, this report may encourage conversations with your healthcare provider about the benefits of CGM technology. Additionally, the findings underscore the importance of maintaining a positive attitude towards self-management and seeking support when needed.
Impact on the World
The “Dexcom State of Type 2 Report” offers a unique perspective on diabetes management in Europe and the Middle East, which can inform global efforts to improve access to CGM technology and diabetes education. This research can also serve as a catalyst for further studies, ultimately contributing to a better understanding of the needs and experiences of individuals with Type 2 diabetes in different regions.
Conclusion
The “Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East” provides a captivating glimpse into the diverse landscape of Type 2 diabetes management in six distinct countries. By shedding light on access to CGM technology, attitudes towards self-management, and healthcare professional recommendations, this report offers valuable insights for individuals living with Type 2 diabetes and healthcare professionals alike. As we continue to strive for better diabetes care and support, studies like this one play a crucial role in informing our collective efforts to make a difference in the lives of those affected by diabetes.
So, whether you’re a curious Type 2 diabetes patient, an enthusiastic healthcare professional, or simply someone looking to expand your knowledge on this important topic, this report is sure to pique your interest and leave you feeling inspired!
